月度归档： 2024 年 4 月

Zhiji, it’s hard to be a prince of SAIC’s new energy vehicle.

For SAIC, Zhiji Automobile is a proper "prince", and it comes with its own aura and is highly anticipated.

Investment from SAIC, Ali and Zhangjiang Hi-Tech recently reached RMB 3 billion, with a valuation of RMB 30 billion.

At the presentation of SAIC’s 2022 semi-annual report, Zhiji was a "major strategic innovation project" of SAIC, and it was also mentioned in the semi-annual report that Zhiji Automobile was an important starting point for SAIC’s "upward development of independent vehicles".

At the beginning of the year, during the worst epidemic in Shanghai, SAIC tried its best to allocate resources to ensure that key new products such as Zhiji L7 went on sale. Zhiji Automobile has also been emphasizing the background of SAIC.

However, the sales of Zhiji L7 are not satisfactory. Since the delivery in late June, the delivery volume is not good. According to the data disclosed by the Association, in September, Zhiji L7 sold 1,019 units, and in July and August, it sold 816 units and 1,007 units respectively.

In the past, there were competitors such as Weilai, and behind them, there was a "direct biography" brother Feifan Automobile, which was about to go public. At that time, it would also seize the resources of SAIC. Can Zhiji afford to be the prince of SAIC?

In January, it sold for 1000 yuan, but it was difficult for the prince to win public support.

In September, the auto market improved.

Recently, according to the latest automobile sales data released by China Automobile Industry Association, the automobile sales volume in September was 2.61 million units, up 9.5% month-on-month and 25.7% year-on-year, maintaining a high-speed growth momentum. Among them, the sales volume of new energy vehicles reached 708,000, a year-on-year increase of 93.9%, and the market share reached 27.1%.　

Tesla’s ModelY sold 51,802 units in September, holding the top spot. The top 30 models have sold more than 5,000 vehicles per month. Among the new forces making cars, Ideal L9 sold 10,123 units. In the pure electric vehicle market with a price exceeding 400,000 yuan, the sales volume of Weilai ET7 in September was 2,928.

"ZhiJi monthly sales of one thousand, must be failed. Although it is said to be a high-end positioning of around 400,000, it will take thousands of units a month, which is similar. " Mr. Zhou, an insider of the car circle, said.

The sales volume is bleak. Besides the brand has just started and its popularity is not high, Zhiji’s investment in channel construction is not strong, which is also an influencing factor.

According to the statistics of Lujiu Business Review, Zhiji has about 40 experience centers and about 35 delivery centers in China. This kind of coverage network is somewhat inadequate.

Taking Beijing as an example, Lu Jiu’s business review learned that Zhiji has only four experience centers in Beijing. Among them, Beitou Shopping Garden Store has just opened on National Day. In contrast, LI has 18 stores in Beijing. Weilai Automobile has 21 stores in Beijing.

Not only that, in terms of distribution channels, Zhiji is also relying on SAIC. During the visit, Lu Jiu’s business review found that several Zhiji sales points in Beijing were made by traditional 4S Buick dealers.

For example, Wangfujing APM store, Zhiji automobile and Buick dealer Gadalai cooperate. Take the mode that Zhizhi pays to rent the storefront, and the dealer hires people to be responsible for the management.

This is somewhat similar to Huawei’s channel vendors, but slightly different. The M5 and M7 sample cars displayed in Huawei Experience Store are all purchased by the store owner himself. The sample cars in Zhiji’s store are directly provided by Zhiji, and dealers do not need to pay for them themselves.

Users book cars online, dealers take sales commissions, and deduct employees’ sales commission and marketing expenses, which is their own profits.

"Zhiji is like this, in order to reduce the pressure on dealers. If you pull the dealer alone, the cost will be invested. If the sales volume does not come up, it will be very troublesome later. " Mr. Zhou said.

When some car companies push new products, they will "apportion" the dealers, and at the same time, they will take some newly pushed models while entering those models that sell well. Mr. Zhou believes that Zhiji’s approach is somewhat similar to this method.

In addition, Zhiji is also conservative in brand investment. "SAIC is a state-owned enterprise, and its budget is very strict, so there are fewer advertisements." The sales staff of Zhongguancun exhibition shop told Lu Jiu’s business review.

If the sales volume does not come up, the turnover of sales staff will be great. "The basic salary of sales is 4,000 yuan. We can probably get 800-1000 yuan when we sell a car. Especially in the past few months, sales have not yet started. Some salespeople can’t sell cars, so they get a basic salary. The pressure in Beijing is great. He left without moving." The sales of Liu, who led the exhibition at Heshenghui, said.

In view of the current sales situation, what further measures does Zhiji have? Lu Jiu’s business review asked Zhiji’s official about this, but as of the time of publication, he didn’t get a reply.

02 35-400,000 range

The prince’s tough battle is not easy to fight.

As the "No.1 Project" of SAIC, Zhiji Automobile has high hopes. SAIC hopes that the Prince will fight hard and attack the independent luxury car market that the Group has not been able to win.

SAIC defines Zhiji as a high-end luxury brand. In the company’s 2021 annual financial report, there is such a description: through the listing of new products such as Zhiji, SAIC Audi and Cadillac, the product camp of luxury brands is further strengthened.

In terms of vehicle size, price and configuration, the target of Zhiji L7 is Weilai ET7. The models with two configurations of Zhiji L7 are priced at 368,800 and 408,800 respectively; The price of Weilai ET7 is about 450,000 to 530,000.

"Wisdom has more control and performance. We call this car the control involution king, which is a bit niche and biased towards those who like to play with cars. " A sales person surnamed Ren told Lu Jiu Business Review.

"We are cheaper than ET7. ET7 is mainly expensive in its service, because they have power exchange service. These are all costs, which will ultimately be reflected in the price of the car." He said that at present, Zhiji L7 has no power exchange service, so the price is cheaper than Weilai.

Compared with Zhiji, Weilai started early, has a strong brand influence, and relies on the unique positioning of "car as a service" to form a strong user stickiness.

In terms of sales volume, there is also a considerable gap between Zhiji L7 and Weilai ET7. Weilai ET7 sold 2,928 units in September and 4,349 units in June.

The prices of two products of Zhiji L7 have reached the price range of BBA. According to public information, only Weilai can occupy a place in the market segment of 350,000-400,000 yuan.

Hi-Tech Intelligent Automobile Research Institute believes that this road of Zhiji is very difficult. The top matching of Zhiji L7 with a price of 408,800 yuan is the model range of BBA, and the general effect will not be very good if the top matching is used to play the low matching of joint venture brands.

Tamia Liu, CEO of Zhiji Automobile, once said: "It is miserable and helpless for users who spend more than 400,000 plus tax close to 500,000 to buy BBA."

Today’s Zhiji car, the differentiated competition has not been shown, but the price and positioning have kept up. This kind of unsynchronization has the most intuitive appearance in sales volume. Although relying heavily on the brand and production and supply resources of SAIC, as an independent luxury brand, Zhiji lacks sufficient persuasion.

Can brothers still sit still when they are competing for the crown prince?

In the past, there were independent brands such as Weilai and many joint venture brands. Behind them, Zhiji Automobile also faced the resource competition of another brother, Feifan Automobile.

Feifan Automobile is an R brand wholly owned and operated by SAIC and its employees, and it is also a brand within SAIC. In contrast, Feifan car is more like a "prince" than Zhiji.

In the planning map of SAIC, it is Zhiji Automobile and Feifan Automobile that promote the development of independent brands. Moreover, Feifan Automobile, like Zhiji, is also a "major strategic innovation project" of SAIC.

Tamia Liu, co-CEO of Zhiji Automobile, has served as an important manager in various positions of SAIC, and has served as product manager, director of market operation department, director of product planning and deputy general manager of quality and economic operation department.

Wu Bing, CEO of Feifan Automobile, has 20 years working experience in SAIC. According to public information, Wu Bing has successively held important positions in several subsidiaries of SAIC-GM, Shanghai Automotive Group Insurance Sales Co., Ltd. and Xiangdao Travel.

Backed by SAIC and endorsed by SAIC is the basic strategy of Zhizhi. In Zhiji’s sales store, the words "Ali makes cars, SAIC quality" are particularly eye-catching.

In manufacturing, Zhiji also relies on SAIC platform. "SAIC has many resources, including the rear wheel steering technology of the car, the design of the chassis, chips and hardware equipment, all relying on SAIC’s supply chain." Ren surnamed sales of Zhongguancun exhibition shop said.

On September 22nd, SAIC announced that it will jointly invest with China Petrochemical, China Petroleum and Contemporary Amperex Technology Co., Limited to establish Shanghai Jieneng Zhidian New Energy Technology Co., Ltd., and will build charging piles at 50,000 gas stations nationwide.

Zhiji characterized this news as good for car owners, and all sales points made publicity signs: "Zhiji’s energy replenishment system will be expanded again, and relying on Jieneng Zhidian, a subsidiary of SAIC, we will fully promote the strong upgrade of the charging network."

Flying every car is the same strategy.

Wu Bing, CEO of Feifan Automobile, was also deliberately highlighting the resources of SAIC in an interview. It has always been emphasized that Feifan Automobile does not start from scratch, "but is carried out on the basis of SAIC’s huge resources".

On September 22nd, SAIC cooperated with PetroChina, Sinopec and Contemporary Amperex Technology Co., Limited, and Feifan Automobile also served as its own resource. Moreover, compared with Zhiji, Feifan and Jieneng Zhidian have a closer relationship.

"SAIC is in a difficult time now, and it is in urgent need of independent brands to do it as soon as possible. In the past, independent brands had a habit of having more brands, having more children and fighting, and the east was not bright and the west was bright. " Mr. Zhou said.

Although Wu Bing has been saying that Fei Fan and Zhi Ji do not constitute competition, in fact, the competition between them is inevitable.

The first is the competition for resources.

Feifan automobile is positioned at the high end, and Zhiji automobile is positioned at the high end. However, the price difference is not very big. The price difference between Feifan and Zhiji is about 50,000 yuan. As two independent new energy brands under SAIC, there is inevitably competition in the undertaking of SAIC brand resources.

In addition, the positioning of the two brands will overlap in the future.

The news learned by Lu Jiu’s business review is that Zhiji will launch a B-class car next year, which is the model that the company wants to take. This B-class car will have direct competition with Feifan.

"In fact, the L7 car is not a real car, it is a brand car. The real car is the B-class car released next year, and the company plans it like this. " "Just like Tesla, the earliest model started at 800,000, and then there were 300,000 models up and down," said Ren, a salesman at the Zhiji exhibition store.

Sales staff revealed that the B-class car released by Zhiji next year will be marked with ET5, Mmodel 3 and other models, which is Zhiji’s brand strategy.

Feifan R7 will be delivered at the end of October, and when the market runs away for some time, especially next year, Zhiji will launch a B-class car, when the two brands will directly fight.

If Feifan’s car sales are improving, SAIC will have to adjust its resource allocation in the case of tight resources.

To prove that he can be a "prince", Zhiji’s time is running out.

The 2023 Shanghai Auto Show will be held from April 18th to 27th.

This newspaper (reporter Yue Qian) recently learned from the official that the 20th Shanghai International Automobile Industry Exhibition (2023 Shanghai Auto Show) will be held in the National Convention and Exhibition Center (Shanghai) from April 18 to 27, with the theme of "Embracing the new era of the automobile industry". Among them, April 18th and 19th are media days, April 20th and 21st are professional audience days, and April 22nd to 27th are professional and public audience days.

It is reported that the range of exhibits at the auto show will include: all kinds of passenger cars, commercial vehicles, new energy vehicles, special vehicles, etc. New automotive energy technologies and products such as batteries, motors and electronic controls; Intelligent networking and other technologies and products; Design and new concept products; Automobile parts, assemblies, modules and systems; Automobile manufacturing equipment, process equipment; Testing, testing and experimental instruments and equipment; Computer development and design system and application technology; Environmental protection technology and products of automobile industry; All kinds of automobile supplies and decorative parts; Automobile maintenance equipment; Promotion and application demonstration, etc.

China quality newspaper

Jinan, the 10 online celebrity places, must punch in in the spring!

Jinan in spring

The wind is gentle and the flowers are brilliant.

Sunlight is the best polishing board

　

Join the hospitable gentleman today.

Unlock it. Young people love it.

Ji’ nan wanghong punch card disco club

　

Wulongtan Park

　

Photography: Dong Chenghua was in Wulongtan in March 2024.

The spring in Jinan has been rubbed into the flowers of Wulongtan. In March, Wulongtan is full of vitality, grass grows and warblers fly, and all kinds of flowers compete to open.

At present, the most amazing things are begonia and cherry blossoms. Clusters of begonia flowers spread, branches spread, and the height is scattered. Pieces of cherry blossoms are colorful and layered, as if to dye the whole sky with powder and white, which is serious and pure!

On a sunny spring day, walk into Wulongtan Park, keep company with romance, meet a tree with flowers, and bump into the beauty of this spring day!

　

Zhang Xia street ten thousand mu apricot blossom forest.

　

Photography: Li Feng was in the street of Zhang Xia in March 2024.

Every spring, the apricot blossoms in Zhang Xia’s 10,000-acre apricot forest are full of branches, and the petals are like a dream, soft and moving, and a sea of flowers and a rosy world suddenly surge out of the mountain village.

Breeze blowing, apricot flowers falling with the wind, like a petal rain, people feel the tenderness and romance of spring.

　

Jinan Laojie Lane

　

Source: Jinan Shengshengman Hanfu Experience Hall

Spring has arrived, but the poetic old street in Jiangnan, which is not drizzling, must not be missed.

The spring water flows slowly with the streets and lanes, the old houses with broken bricks and tiles, the green springs with swaying green algae, the streets and lanes with shady willows, flowers and trees, friends wearing Hanfu and hairpin flowers … There are amorous feelings everywhere.

　

Spring City Square

　

Photography: Li Feng was in quancheng square in March 2024.

Yang and qi sting, and everything is spring. In spring in Jinan, there are not only willows hanging by the lake, but also tulip flowers in quancheng square. They are synonymous with romance in the living room of Quancheng. In the name of spring, they water the earth with charming colors.

Take a group of beautiful photos and leave spring in the album.

　

city moat

　

Photography: Shao Kai was in the moat in March 2024.

Maybe we can punch in the spring city in another way, take an antique boat boat and take a look at the beautiful spring water in the old city of Jinan along the moat.

All the way through the spring bridge pavilion, I saw weeping willows, blooming flowers and picturesque scenery on both sides of the river, listened to the painting boat "singing" the spring water across the water and felt the gentle stroke brought by the spring breeze. ……

　

Jinan Zoo

　

Photography: Shao Kai was in Jinan Zoo in March 2024.

Take advantage of the sunny day, walk into Jinan Zoo and feel the real version of "zootopia"!

There are many kinds of animals: giant pandas, giraffes, flamingos, rhinoceroses, peacocks, and monkeys that have recently been "out of the circle" because of their expressions, all of which are worth seeing.

　

Daming Lake Chaoran Building

　

Photography: Liu Hongbin was in Chaoran Building in March 2024.

Chaoran Building is still a popular punching place for online celebrity in Jinan. Whenever night falls, the lights of Chaoran Building will light up on time, reflecting this quaint and elegant building like a dream.

Outside the building, the willows hang down and the flowers are in full bloom, which is in harmony with the transcendental building. Walking among them, it seems that you are in a flowing ancient painting!

　

Ziyeli boulevard, Huanghe Daba

　

Photo: Wang Xiao was at the Yellow River Dam in March 2024.

Every spring, Ziyeli Avenue of the Yellow River Dam is full of flowers and clouds, stretching for dozens of kilometers.

In spring, ride, enjoy flowers, watch sunsets and have a romantic spring here.

　

jinan library

　

Photography: Li Feng was in the Third Western Pavilion in April 2023.

In spring, in addition to the fragrance of flowers, the most intoxicating thing is the books that exude a touch of ink! In a leisurely afternoon, it is best to come to Jinan Library to enjoy reading!

This is the place where Sa Beining punched in with "Ceng Gong", and the super-hot evening course is about to go online. Come and punch in!

　

Mingshui ancient city

　

Source: Mingshui Ancient City

White walls and grey tiles, small bridges and flowing water, criss-crossing streets and lanes, winding rivers, gushing springs and antique, this is Mingshui Ancient City, a beautiful city with beautiful mountains and rivers punched by CCTV.

Last week, Hunan Satellite TV & Mango TV’s popular variety "All Staff Accelerates the Battle Season" was recorded here. Come here, punch in the places explored by CCTV and feel the charm and historical traces of the ancient city.

Spring is a season to live up to.

The sun is warm, the breeze is gentle and the flowers are in full bloom.

In this season when even time is tender.

To Jinan, these online celebrity punching places.

Collect unique little beauty.

Source: Jinan Culture and Tourism Bureau

Will the writing robot ＂live＂ artificial intelligence replace human beings in one minute？

　　Will this happen? Cai Hua Wei hui

　　Not long ago, at the Weiqi Summit in Wuzhen, China, the artificial intelligence program "Alpha Dog" played against China Weiqi professional nine-stage player Ke Jie, ranking first in the world, with a total score of 3: 0. Prior to this, it had defeated Li Shishi, a Korean professional nine-stage chess player who was also the world champion of Weiqi, with a total score of 4∶1, and played fast chess against dozens of Weiqi masters from China, China and South Korea with the registered account of "Master" on the Korean chess website, without losing for 60 consecutive games. In the past two years, "Alpha Dog" has swept the chess world of China, Japan and Korea, and its performance is perfect every time.

　　All along, there has been a view that the development of artificial intelligence will threaten the survival of human beings, and the fact that "Alpha Dog" can repeatedly defeat human beings in a typical Weiqi game that reflects human wisdom has aggravated some people’s worries.

　　So, how big is the direct impact of artificial intelligence on people’s work and life? It has some human abilities, even better than human beings. Will it compete with human beings in the future and even pose a threat to us?

　　Have a must

　　Comparable advantage

　　In the future, artificial intelligence can make high-level predictions and decisions in financial investment, medical diagnosis, enterprise management and military command.

　　Will artificial intelligence replace human beings? It should be said that this kind of worry also has some truth.

　　In recent years, the development of artificial intelligence in all aspects is gradually improving, with more and more applications, and its performance has surpassed that of human beings in many aspects.

　　For example, in September 2015, Tencent Finance launched an automated news writing robot. It can automatically generate manuscripts in the first time according to the algorithm, output analysis and judgment instantly, and deliver important information and interpretation to users within one minute.

　　Also, Microsoft Xiao Bing, as a virtual companion robot, can simulate people’s tone and talk to people, making people feel that this is a living person rather than a machine when chatting.

　　In addition, according to foreign media reports, JPMorgan Chase has developed a financial contract analysis software, which takes only a few seconds to complete the work that lawyers and credit personnel need 360,000 hours a year, and the error rate is greatly reduced.

　　Liu Xiwei, deputy director of the Institute of Wisdom Education of Qingdao Intelligent Industry Research Institute, said: "In terms of problem solving, artificial intelligence programs have been able to know how to consider the problems they want to solve, that is, search the solution space and find better solutions. In terms of driverless driving, artificial intelligence has been able to achieve autonomous driving under long-distance complex road conditions. "

　　"In the future, at the cognitive level, artificial intelligence will have a broad application space. For example, artificial intelligence can make high-level predictions and decisions in financial investment, medical diagnosis, business management, and military command." Sun Zhenan, a researcher at the Institute of Automation, China Academy of Sciences, said.

　　The famous physicist Stephen Hawking believes that the impact of artificial intelligence on human society will be even greater. At the end of 2016, he published an article in the British "Guardian" predicting: "The automation of factories has caused many traditional manufacturing workers to lose their jobs. The rise of artificial intelligence is likely to spread the unemployment tide to the middle class, leaving only care, creation and supervision for human beings."

　　Such a judgment remains to be verified in the future, but compared with human wisdom, artificial intelligence does have incomparable advantages.

　　Liu Xiwei said: "Compared with the human brain, artificial intelligence algorithms should be more accurate, fast, stable and reliable in numerical and symbolic calculations. Especially for computing problems with definite rules, artificial intelligence can far exceed the computing speed of human brain, and it is easier to find the optimal solution. For example, in numerical calculation, recognition of graphics, voice, biological characteristics, behavior and posture, and even more complex predictive reasoning tasks, artificial intelligence has outstanding performance beyond the human brain. "

　　Will not replace

　　Even threaten mankind.

　　Artificial intelligence doesn’t have perceptual thinking and can’t cross into the field of consciousness.

　　So, will artificial intelligence really replace human beings and even pose a threat to us? Several experts interviewed by the reporter gave negative answers.

　　First of all, experts believe that the current computer architecture and programming mode are inherently inferior, which makes it impossible for artificial intelligence to realize natural interaction with human emotions, will, mentality, emotions and experience. In essence, artificial intelligence is only the concept of the material world category, and it can’t cross the field of consciousness.

　　Dr. Roger Sperry, who won the Nobel Prize in Physiology in 1981, once published the famous "theory of division of labor between left and right brain", arguing that the left hemisphere of the human brain has different division of labor: the left hemisphere is good at rational abstract thinking such as analysis, logic, deduction and reasoning; The right hemisphere is good at perceptual image thinking such as intuition, emotion, art and inspiration. So far, all the intelligent performances of artificial intelligence only imitate the rational thinking mode of human left hemisphere, but do not have the perceptual thinking of right hemisphere at all.

　　"That is to say, the current artificial intelligence technology is still difficult to deal with all kinds of problems in the social, cultural and conscious fields that have a significant impact on human subjective consciousness, while the human brain can easily cope with such problems through long-term learning and growth in a complex social environment." Liu Xiwei did not say.

　　He further cited, for example, that artificial intelligence has not yet created a truly human-oriented work. "Computer and human brain, after all, have the essential difference between mechanical and life spirit, so there is still an insurmountable gap between computer creation and human brain creation. Individualization is the life of human literary and artistic creation. There is no individuality in the existing computer creation system, but it is only the imitation, reproduction and reorganization of existing works of art. "

　　Then, with the continuous development and improvement of artificial intelligence, is it possible to realize this spontaneous emotional intelligence in the future?

　　"Emotional intelligence is divided into two levels, one is to let the machine have emotion, and the other is to let the machine understand people’s emotions. They are different," said Yi Jianqiang, a researcher at the Institute of Automation, China Academy of Sciences. "It is possible to let the machine understand people’s emotions. At present, some robot systems can partially understand the scene, environment and dialogue content, and make corresponding reactions or expressions according to the results. However, it is difficult or impossible to achieve a robot or artificial intelligence system that fully reaches the level of human beings and has spontaneous emotions and creativity. "

　　Wang Feiyue, vice chairman and secretary general of China Automation Association, agrees with this. "I personally think that it will not be realized in 100 years, and it may never be realized unless we redefine what is human emotion, understanding, reasoning and so on. The reason is very simple. People still don’t know the connotation, process and way of these emotions. "

　　Will become human

　　Accelerator of development

　　Artificial intelligence does have a certain impact on human employment, but human work will not disappear, but will be transformed into new forms.

　　Scientists also believe that artificial intelligence technology is just a new tool created by human wisdom, which helps mankind to make breakthroughs faster and improve our ability to deal with those global problems that need to be solved urgently.

　　"We need artificial intelligence as a powerful tool to help deal with complex problems, predict the unknown, and support us to achieve previously impossible goals." Wang Feiyue said.

　　Experts say that many epoch-making scientific and technological achievements will inevitably lead to changes in people’s lifestyles, which may be difficult to accept in the short term. However, if we look at the long river of history, we will find that all major scientific and technological revolutions will eventually become accelerators for human development without exception, and at the same time, they will also be the fundamental guarantee for improving the quality of human life.

　　"The same is true for the emergence of artificial intelligence technology, which will indeed have a certain impact on human employment. For example, artificial intelligence is more suitable for dealing with simple repetition, rule determination or finding effective rules through case study. It is more efficient and reliable to hand it over to artificial intelligence, such as security inspection, watching pathological sections and monitoring video audits, and these types of jobs are therefore more vulnerable to impact and substitution. " However, Yi Jianqiang said that there is no need to worry that it will completely replace human beings. "Take the first industrial revolution as an example. It not only replaced the existing jobs of human beings, but also created enough new employment opportunities. In most cases, work has not disappeared, but has changed into a new form. "

　　Yi Jianqiang said that the replacement of carriages by cars is a very typical example. At that time, when cars began to enter big cities and gradually spread, carriages that had been used as travel tools for hundreds of years faced the threat of being laid off. However, it turns out that the newly emerging automobile industry has thousands or even tens of thousands of times more output value and job opportunities than the traditional carriage industry.

　　"At this stage, in a working scene that truly realizes artificial intelligence, traditional workers have not been ‘ Laid off ’ , just changed the role. Humans still need to monitor the performance of artificial intelligence, collect and analyze information, conduct predictive experiments and evaluations, and guide process management and control. " Wang Feiyue said, "I believe that more than 90% of human work will be provided by artificial intelligence in the future, just as most of our work today is provided by computers and various other machines." (Reporter Wu Yuehui)

Dongguan： A quarter of the global animation derivatives are made in Dongguan.

Shenzhen Special Zone Daily, Dongguan, March 28th (Reporter Shen Weifeng) Yesterday, the 14th China Children’s Industry Development Conference and China Brand Authorization Annual Meeting hosted by China Toys and Baby Products Association opened in Dongguan. With the theme of "Foreseeing the New Symbiosis in 2024", this conference invites guests to face-to-face exchanges and seek common development, promotes exchanges and cooperation between relevant industries in Dongguan and other regions, injects new vitality into "China Tide Play Capital" and jointly promotes the high-quality development of the national toy and baby products industry.

"World toys look at China, and China toys look at Dongguan." Dongguan toy manufacturing industry started in the early days of reform and opening up, and now has more than 4,000 toy manufacturers and nearly 1,500 upstream and downstream supporting enterprises, making it the largest toy export base in China. According to statistics, at present, a quarter of the global animation derivatives are produced in Dongguan, and nearly 85% of China’s trendy games are produced in Dongguan. In 2023, the output value of Dongguan’s toy manufacturing industry was 26.217 billion yuan, of which Chaowan was close to 20 billion yuan. At present, Dongguan has formed a toy industry base with Shipai, Qingxi, Fenggang, Chashan and other towns as key areas, with remarkable industrial agglomeration and complete industrial support.

Wen Guoxiong, vice president of China Toys and Baby Products Association, said that China Toys and Baby Products Association is planning to set up a 5,000-square-meter exhibition center in Guancheng City to attract famous animation IP at home and abroad to Dongguan. In addition, the association also actively attracts talented people from animation associations, theaters and schools in China to help Dongguan improve the front-end industrial chain.

The first generation of Tik Tok online celebrity ＂went down to the altar＂

Text | Vince An　

After the rise of short videos, for Tik Tok, star-making seems to happen overnight. From 2017 to 2018, Xiao Ye gained tens of millions of fans from an unknown ordinary person because of some interesting videos, and even became popular on YouTube abroad.

There is Wen Wan, a former elder sister in Tik Tok, who once became popular with her video of rocking with music in the parking lot, and the number of fans in Tik Tok exceeded 10 million in ten days. In 2018, with a hip-hop dance video, Degula K gained 5 million fans in just ten days. At present, her fans have exceeded 25 million. It is reported that the price of one of her videos is over 400,000, which has surpassed her classmate "Office Xiao Ye".

Even so, the vitality of Tik Tok online celebrity is hard to last. Is this caused by platform users’ aesthetic fatigue, liking the new and hating the old? There is no IP with long-term precipitation, so today, when the live broadcast boom is sweeping, Tik Tok seems to be somewhat behind Aauto Quicker and Ali.

There is no IP in online celebrity, Tik Tok

Everything that is quick may also rot quickly.

On January 6th, the Annual Report of Content Industry in 2020 released by the new list mentioned that only 1.4% of the Top100 accounts in Tik Tok were listed for more than 10 times. Most accounts are quiet or even disappear after a night of scenery, which makes people wonder at the fast iteration speed of Tik Tok and online celebrity.

According to media reports, in August, 2019, two children made popcorn videos after imitating a pop can in Tik Tok. Because they didn’t have relevant knowledge, they were injured in an explosion, and one of them died unfortunately. In view of the suspicion of guidance, on September 17, 2019, one family member and Onogata signed a settlement agreement. Previously, the imitated "Office Xiao Ye" team had paid the two parties a total of about 800,000 yuan in aid.

Since then, Xiao Ye’s office has been closed one after another, and he has not returned until now. At present, the update of Xiao Ye in the office is basically the content of new colleagues, and the broadcast volume is not as good as before.

Wen Wan’s side, before enjoying the bonus of online celebrity traffic, was given the title by Tik Tok. This phenomenal online celebrity used to have a large amount of privacy outflow, and his plastic surgery, dropping out of school and hanging out in nightclubs … were not too likable. And it’s hard to brush Dygula K in Tik Tok. Some netizens questioned, "It’s all the popularity of brushing. I accidentally saw her live broadcast that day, and the live broadcast room was hundreds of people" …

It is worth mentioning that Li Ziqi, with his short pastoral video, has made countless fans around the world, and the total revenue of YouTube and Taobao stores is said to exceed 100 million. In August 2018, her Tmall store "Liziqi Flagship Store" officially opened. On the day when the store was launched, the sales volume of some commodities exceeded 10,000; After three days on the line, the sales reached 10 million yuan, but now the sales of its popular food products only break through 10 thousand per month. According to the Baidu index, its attention has generally dropped by more than 60% compared with the peak period.

A new trip that I can’t catch up with

Some insiders told Yiming. com that the active cycle of short video online celebrity is mostly within half a year.

At the moment when the algorithm is in power, in the fragmented time, if you want to attract attention and praise, you can only do entertainment and eye-catching content. In order not to make mistakes and save time and cost, the creator must seize the platform users in just a few minutes or even dozens of seconds, but in fact, there are very few valuable contents that users can watch in this process.

Of course, short video players are mostly just for fun. Therefore, even the creators who are eager to create powder-sucking through deep content have to compromise the user’s preferences because of the data such as the number of fans and the number of likes, and follow the trend of some short videos.

According to the Annual Report of Content Industry in 2020 released by the new list, in 2019, 53.2% of the accounts were on the TOP100 of WeChat monthly list, 9.7% were on the TOP100 of Taobao monthly list, and 1.4% were in Tik Tok.

"Many online celebrity actually became popular at first without knowing what was going on, perhaps just catching up with a hot spot or catering to a certain trend," a senior practitioner in an industry said in an interview with Yiming. "But they lack the ability to follow up, so even if they stand out at once, they will soon disappear from everyone."

An executive of MCN organization in Shanghai thinks that Tik Tok has a staged content tendency and traffic support, because once the creators make a little achievement, they are easy to form path dependence, and it is difficult to get out of the comfort zone, such as Dracula K. Perhaps at first, everyone was interested in singing and dancing, and Tik Tok also gave such creators a traffic tilt, so that they could get higher-frequency exposure. However, as time goes by, users’ sensitivity to such short videos decreases, and the stimulation threshold keeps increasing, that is, aesthetic fatigue in the usual sense.

In order to revitalize traffic, Tik Tok can only use new forms to incite the ecological development of platform content, as can be seen from the revision of Tik Tok at the beginning of last year. In April last year, Tik Tok announced the full opening of users’ 1-minute video rights, and launched the "Vlog Billion Traffic Support Plan" to encourage ordinary users to record their lives and create content in a richer way.

Prior to this, new users could only shoot short videos for 15 seconds, and it took 1,000 fans to open a video for 1 minute. However, the decline in user stickiness and the increasingly serious homogenization of content have forced Tik Tok to speed up the pace of reform. Moreover, the longer the duration, the more sticky the users are. After all, Tik Tok mainly focused on harvesting the fragmentation time of users.

However, more and more companies are adding vlog to short videos, and platforms such as Baidu Good-looking, Weibo and bilibili are all eyeing up. Subsequently, live broadcast with goods suddenly rose, and Li Jiaqi and Viya helped Taobao refocus, which became a hot topic in the limelight. Aauto Quicker, however, is also working with Xin to cut the cake of live traffic.

Can’t catch the live broadcast, it’s hard to compete.

Live e-commerce has always been a shortcoming of Tik Tok, and advertising business is its lifeblood. Based on the characteristics of algorithm recommendation and centralized traffic distribution, Tik Tok’s advertising has a strong diversion effect, but in this mode, users are not very sticky, and private domain traffic is difficult to obtain and gather, which makes it difficult to form an e-commerce head anchor by relying on the natural incubation of the community.

Anxious, Tik Tok saw Ali and Aauto Quicker laughing and proudly broadcasting the goods, and happened to hit it off with Lao Luo, who was working to pay off debts. According to Tik Tok’s data, the first live broadcast in Luo Yonghao lasted for 3 hours and 17 minutes, with a total of 48.922 million people watching, of which 588,000 people gave gifts, with a total harvest of 36.327 million sound waves, 23 goods were put on the shelves, and the total payment transaction amount exceeded 110 million yuan.

The good performance of the first show made Tik Tok very excited, and the industry even thought that Tik Tok had the strength to compete with Taobao and Aauto Quicker. However, the debut is the peak. From April 1 to now, there are 14 live broadcasts in more than three months. The data of Lao Luo’s live broadcast room has been declining all the way, and the sales volume has dropped by 80% compared with the first one.

To Tik Tok’s surprise, Lao Luo didn’t become the king with goods comparable to Li Jiaqi and Viya. According to the June list data of GMV Monthly List of Live E-commerce Anchors released by WeMedia, Viya, Simba and Li Jiaqi are still in the top three rankings, but Luo Yonghao ranked 47th.

Nowadays, the first generation of online celebrity in Tik Tok has either fallen or failed to grasp the outlet of live broadcast with goods, and is silent and nameless. But Tik Tok itself, except advertising business, has no more sustainable commercial value. Although the trend of live e-commerce is clear, it is difficult for Tik Tok and Tik Tok online celebrity to rewrite their short-lived fate.

On the other hand, it reveals that the core of e-commerce still lies in the control of supply chain, but so far we have not seen the advantages of Tik Tok in these places. Therefore, once the traffic is exhausted, and there is no idea of sustainable and diversified development, Tik Tok can only be on the defensive in the competition of other platforms.

With the expectation of ＂Wind＂, can the spy film ＂Knife Point＂ reach another peak？


Special feature of 1905 film network　Based on the novel of the same name, the spy war giant system was released nationwide today. This film tells the story of Nanjing during the Anti-Japanese War, when the Japanese and the puppet governments infiltrated each other, and the ace agents Jin Shenshui (ornaments) and Lin Yingying (ornaments) walked on the tip of the knife with a group of agents with different ambitions.



This time, the Mai family in Gao Qunshu joined hands again, and then can it once again become a brand-new legend of spy war?



After "Wind", "Knife Point" is hard to reach the peak again.


How popular was The Wind in those days? In 2009, the spy film Wind, which was directed by Gao Qunshu and adapted from Mai Jia’s novel, was born, winning 235 million box office, which not only set off a frenzy of contemporary spy film creation in China, but also won the highest score of Chinese spy film with a score of 8.4, and won numerous awards at major film festivals and award ceremonies, becoming the peak of China spy film.



After The Wind, the spy war masterpiece Knife’s Tip was filmed. Director Gao Qunshu said frankly that he was going to shoot something different and focus on the relationship between the times and fate. Therefore, the story background of this film was set in Nanjing under the rule of Wang puppet regime in 1940, rather than Shanghai, where spy war works were the most common.


In the propaganda of Knife’s Tip, what worries Gao Qunshu most is how to make people not associate with Wind. In his view, "Knife’s Tip" is about the choice and helplessness of personal fate in the complex and turbulent era at that time, but it just happens that the role is an agent.



However, judging from the artistic quality of the films, there is indeed a certain gap between the two films. The movie The Wind has a higher degree of completion, and the story is simple, focusing on a specific thing like a script killing, while The Knife’s Tip has a richer plot and tells a bigger story, but the details in its story, including the relationship between characters and stories, the relationship between styles and themes, are not complete enough, and the feeling of holding the audience away from the wind is missing!



It is difficult to hide the shortcomings of group play when the bones of the play gather together


The cast of this film is also very strong, starring Zhang Yi, Lang Yueting, and starring,,,,,,, especially. It is expected that a number of actors will join us.


In this film, Zhang Yi plays the special agent Jin Shenshui, who has multiple identities, and walks among the forces of the Japanese military, the puppet government and the military junta, just like walking at the tip of a knife. Zhang Yi said that the growth process of the role is the awakening of an agent. From the beginning, it was just for revenge, to finding faith with the help of comrades-in-arms and moving closer to anti-Japanese organizations, we can see the growth of the role "from iron to steel".



In addition, Gao Jie’s eagle dog, who plays the role of "profit" in this film, is full of malice and malice. Cheng Taishen, just sitting quietly in the picture, didn’t say a word, all is wily.



However, although the film Knife’s Tip is a gathering of drama bones, it is not satisfactory in shaping the group scenes. In contrast, in the movie "Wind", there are big flowers competing with each other, and there are also small students fighting with each other. In the first hour of the movie, the game scenes between the protagonists leave a lot of room for the group drama of the movie.



The complex relationship between the characters and the multiple identities and tasks of the same character in Knife’s Tip made the audience feel "brain-burning". In order to tell the story completely, the director hid a lot of plot information in these two hours. Therefore, in the second half of Knife’s Tip, several core characters showed a sense of panic to the audience with the rhythm of one victim for ten minutes. Such a change in the fate of the characters, because the development time is too short, it is difficult for the audience to have enough cognition and judgment on the characters. In the movie, except for three main characters, such as Jin Shenshui, with some characters’ arcs, all other characters serve the plot like NPC, and there is no room for other characters to grow and change.



On the other hand, there will be some misplacement between the way the characters are portrayed in this film and the appreciation habits and levels of the current mainstream audience. For example, in the scene of Li Bingbing and Zhou Xun in The Wind, the mutual verbal test and the change of expression in the camera will give the audience the pleasure of reading and make people look very enjoyable. However, when the Japanese army suspects Lin Yingying in Knife Point, her defense is to cover for herself by revealing the shortcomings of others, and this process of revealing shortcomings is very direct, which makes people feel that its overall plot and lines are not intelligent enough.



If we look forward to the Wind and see the Blade’s Tip, which may be disappointing, but if we just look at the Blade’s Tip, will we be moved by its ups and downs, suspense and thrilling confrontation between light and dark? Let’s go into the cinema and find out!


Women complain that Xiaomi SU7 has not delivered the painted Xiaomi car： relevant policies will be issued to solve it.

Recently, after the launch of Xiaomi SU7, it was sought after by many people. However, Ms. Mo from Shenzhen, Guangdong Province was upset because she bought the original version of Xiaomi SU7. Her car has not been received yet, but she was told that the car bumped during transportation and the paint fell off the front cover.

According to @ Leng Wen Video, on April 4th, in Shenzhen, Guangdong Province, Ms. Mo issued a document saying that she bought the original version of Xiaomi SU7 car, and when the car arrived, she was told that there was a bump in the transportation process, and a piece of paint was covered in front of the car, so she could only make up the paint and pay 5000 points (the purchasing power in Xiaomi Mall is equal to 500 yuan) and then deliver it normally.

After Ms. Mo said that she refused, the other party proposed a solution of compensation of up to 20,000 points, which did not support the replacement of a new car, and the deposit for returning the car could not be refunded. Ms. Mo refused again, and Ms. Mo insisted on replacing the new car.

For this matter, Xiaomi Automobile customer service said that it is impossible to replace a new car, and it will take a long time to reorder. You can negotiate with the delivery center and follow up with relevant policies to solve such problems.

The staff of Shenzhen Xiaomi Delivery Center said that there will be a person in charge of the delivery center to deal with the privacy of the owner.

In this regard, some netizens said that the collision of new cars is obviously a non-consumer responsibility, and Xiaomi Automobile only compensates for points. This after-sales service is too perfunctory!

Some netizens also said that Xiaomi’s mobile phone did a good job, but I didn’t expect such a mistake in the automotive field.

Source: @ 中中中中中, Red Star News

In the face of the ＂cliff-like＂ decline in the price of centralized mining, how to deal with the heart stent enterprises？

Sheng: the "past lives" of heart stent

Cardiac stent, also known as coronary stent, is a high-value consumable commonly used in percutaneous coronary intervention (PCI), which has the function of dredging arterial blood vessels and is recognized as a conventional treatment for cardiovascular diseases. Since the first generation of stents went on the market in 1997, the development of cardiac stents has gone through three stages, the first generation is the balloon expansion era, the second generation is the bare metal stent era, the third era is the drug-eluting stent era, and it is now moving towards the fourth generation of completely degradable stents. With the continuous evolution of materials, the performance is more and more optimized. The main features of each generation of cardiac stents are as follows:

Fig. 1 development of cardiac stent

At present, non-degradable drug eluting stent,DES) is still the mainstream choice for clinical application, and fully degradable stent is still in the early stage of product development and clinical application. At present, the mainstream cardiac stents in the market are still drug-eluting stents, and the market share has remained at around 99% since 2012, and balloons and bare metal stents have been completely replaced by them. Biodegradable stents (BRS) can be gradually absorbed in the body, which can significantly reduce the formation of stent thrombosis and restenosis, at the same time, it will not affect MRI and CT scanning, and also facilitate the re-intervention process. It is the main direction of stent research and development in the world, and has attracted extensive attention from medical device companies at home and abroad. At present, the fully degradable heart stents put into research and development are mainly divided into two categories: degradable metal materials and degradable polymer materials.

Fig. 2 Types of mainstream cardiac stents currently in use

(A) In recent years, the demand for cardiac stents has been increasing, and the scale has steadily increased.

1. The number of PCI interventions in China ranks first in the world, and the number of PCI interventions has increased by over 15% annually in recent five years.

From 2015 to 2019, the number of cases of percutaneous coronary intervention (PCI) in China increased steadily, with an average annual increase of 16.0%. Among them, the number of percutaneous coronary intervention (PCI) in China in 2019 was 1.03 million, ranking first in the world, with an increase of 12.6% compared with 2018. It is conservatively estimated that there will be nearly 1.2 million cases of percutaneous coronary intervention (PCI) in China in 2020.

Fig. 3 Trends of PCI operation volume in China from 2015 to 2020 (data source: analysis by Health Research Institute).

In 2020, the market value of heart stents in China is close to 17.5 billion yuan.

From 2015 to 2019, the number of cardiac stents implanted in China showed a steady growth trend year by year, with an annual growth rate of 15%-20%. In 2019, the number of cardiac stents implanted in China was 1.6 million. In terms of market value, the market value of heart stents in China increased from 9.75 billion yuan to 15.97 billion yuan from 2015 to 2019, with an average annual growth rate of 15.2%. It is estimated that the market value will be close to 17.5 billion yuan in 2020.

Fig. 4 Trend chart of cardiac stent implantation quantity and scale in China from 2015 to 2020 (data source: analysis by Health Research Institute).

(B) The "market just needs+policy orientation+technology promotion" troika escorts the rapid development of the cardiac stent industry.

1. The market just needs:The two major trends of younger coronary heart disease and aging population have once again "expanded" the cardiac stent market.

Younger coronary heart disease:Cardiovascular disease has become the number one health killer in the world, accounting for nearly 30% of the total global deaths. According to China Cardiovascular Health and Disease Report 2019, the number of cardiovascular patients in China reached 330 million, accounting for more than 45% of the deaths of residents, ranking first among all diseases. Among them, the number of patients with coronary heart disease has reached 11 million, with more than 3 million new patients each year and more than 1 million patients with sudden infarction. In addition, the younger trend of coronary heart disease (CHD) is increasing. According to a survey of cardiovascular diseases among more than 20,000 people in Shanghai, the number of patients with CHD accounts for nearly 30%, of which 27.0% are over 70 years old, 40.0% are 51-70 years old, and 33.0% are under 50 years old. CHD is no longer a "patent" for the elderly, and it is obese, stressful and stressful.

Figure 5 Proportion of cardiovascular disease population structure (data source: public information)

Aging:According to statistics, in 2019, the population aged 65 and above accounted for 12.6% in China. From the development trend, the population aging speed and scale in China are unprecedented. After 2022, China will enter a deeply aging society with a proportion of over 14.0%, a super aging society with a proportion of over 20.0% around 2033, and then it will continue to rise to 35.0% in 2060. The arrival of the era of deep aging will undoubtedly raise the "ceiling" of the heart stent industry.

Figure 6 Structural trend of population aging in China (data source: public information)

With the development of younger coronary heart disease and aging population, and considering the impact of centralized procurement on the price of cardiac stents and the improvement of people’s health awareness, the number of PCI operations per capita in China will be in line with that of developed countries in the future (the number of PCI operations per million population in China is 736, that in the United States is about 3,135, and that in Japan is about 2,047, which is 4.3 times and 2.8 times that in China, respectively). According to the extreme analogy method (referring to the number of PCI operations per million people in Japan, mainly considering that China and Japan are similar in race and incidence), it is estimated that the peak number of PCI operations will reach 2.87 million in the future. Considering the average number of stents implanted in PCI (about 1.5 stents/case), the corresponding peak number of cardiac stents implanted is about 4.3 million, which has a large long-term permeability and market space.

Fig. 7 Comparison of the number of percutaneous coronary intervention (PCI) between China and major developed countries (data source: analysis by Health Research Institute).

2. Policy orientation:Front-end encouraging innovation and end-collection specification help the market demand of cardiac stents to be released continuously.

In recent years, the state has launched a series of favorable policies for the medical device industry to support the rapid development of enterprises:

innovateEncourage the acceleration of the transformation and upgrading of medical devices, develop high-end interventional products such as fully degradable vascular stents, and stimulate the development of new cardiac stents market segments; Priority is given to the review and approval of qualified innovative medical devices. Under the promotion of innovation policy, the fully degradable polymer matrix drug (rapamycin) eluting stent system (NeoVas) independently developed by Lepu Medical and the fully degradable polylactic acid stent (Xinsorb) independently developed by Academician Ge Junbo of China Academy of Sciences have all entered the special approval procedures for innovative medical devices.

circulateFrom the national level to the provinces and cities, the centralized purchasing scheme of high-value consumables has been launched one after another, constantly rationalizing the price system of high-value medical consumables and improving the supervision and management of the whole process. In October 2020, coronary stents became the first batch of purchased varieties, and the national level started the collection of high-value medical consumables.

Table 1: Main policies related to high-value consumables such as cardiac stents from 2016 to present:

3. Technology promotion:The iterative upgrading of products and the improvement of interventional surgery level greatly enhance patients’ confidence and willingness to receive interventional therapy.

Iterative upgrade of products: cardiac stent has experienced the development from balloon expansion to drug-eluting stent, and the restenosis rate of stent implantation has decreased by nearly 20%, and the incidence of thrombosis in stent has decreased to about 1%, which effectively reduces the risk of complications for patients;

Improving the level of interventional surgery: China has successively established the training base of cardiovascular interventional diagnosis and treatment of the Ministry of Health and the national quality control center of PCI, and adopted a unified training model to carry out systematic training nationwide, and issued certificates after passing the examination, and carried out quality control and index monitoring on related work. In 2018, the mortality rate of interventional therapy for patients with coronary heart disease was 0.26%, far lower than that in the United States.

(III) Competition pattern: Domestic substitution in the cardiac stent industry has basically been completed.

After decades of development, the technical generation gap among major enterprises has gradually narrowed, and the industry pattern has been basically stable, mainly relying on the launch of new products to enhance market share. Judging from the competition pattern, the concentration of cardiac stent industry is high, and the market share of domestic drug stent products exceeds 70%, and the domestic substitution is basically completed. Among them, domestic brands such as Weichuang, Lepu and Jiwei rank among the top three, with a total market share of over 65%.

Figure 8 Market share of domestic cardiac stent brands in 2019 (data source: analysis by Health Research Institute)

In 2019, the revenues of cardiac stents (including balloons, catheters and other ancillary products) of minimally invasive medical care, Lepu medical care and Jiwei medical care were 1.83 billion yuan, 1.79 billion yuan and 1.74 billion yuan respectively, with growth rates of 33.0%, 26.7% and 24.9% respectively. As can be seen from the figure, cardiac stents of minimally invasive medical care showed a trend of "double high" in sales growth rate and market share.

Figure 9 Market share and revenue growth rate of cardiac stent head enterprises (data source: analysis by Health Research Institute)

Change: the national "group purchase" triggered a major change in the heart stent industry.

With the landing of the national heart stent collection, the "suicide" price reduction of enterprises has also brought infinite reverie to the future direction of the industry. Will the heart stent industry under centralized procurement be a "broken wrist" or a "rescue" in the future? Is it "price for quantity" or "innovation and transformation"?

(A) the change in scale

Centralized procurement of cardiac stents directly affects the purchase price. According to the recent centralized purchasing list published by the Medical Insurance Bureau, the number of intentional purchases in the first year exceeded 1.07 million, involving 27 products. Based on the published average price quoted by the winning bidder (1682 yuan/piece) and the amount of coronary stents implanted in 2021, the market value in 2021 is about 3.19 billion yuan. It should be emphasized that the market value forecast here does not consider the impact of the decline in centralized purchasing price on the improvement of patients’ willingness to operate.

Fig. 10 Market value forecast of cardiac stent in 2021 (data source: analysis by Health Research Institute)

According to the previous estimation of the amount of cardiac stent implantation in China, when the amount of PCI operation per 100 people reaches the Japanese level, the peak amount of cardiac stent implantation in China is 1400 x 2047 x 1.5 = 4.3 million. According to the heart stent of 1682 yuan/piece (the average price of centralized procurement), the corresponding market value of heart stent is 7.23 billion yuan:

Fig. 11 Market value of China cardiac stent corresponding to peak value (data source: analysis by Health Research Institute)

From the above analysis, it can be seen that under the influence of centralized procurement policy, the market value of heart stents in China in the next 1-3 years is expected to be in the range of 3-7 billion yuan.

How much money can patients save after centralized collection?

As we all know, the "floor price" of centralized purchasing has a great influence on patients who are unwilling to undergo interventional surgery because of the high price. This paper analyzes the payment situation of patients before and after centralized purchasing (according to the conventional reimbursement policy):

Fig. 12 Comparison of patients’ self-funded amount before and after centralized purchasing (data source: analysis by Health Research Institute)

As can be seen from the above figure, according to the same reimbursement policy, the out-of-pocket medical expenses of patients decreased from 6520 yuan to 308 yuan before and after centralized purchasing, and the personal burden was only 4.7% of the original, which greatly eased the economic burden.

(2) Changes in business

In addition to the industry scale being affected, the business tentacles of heart stent enterprises will also be adjusted:

1. Stent market: form a low-cost medical insurance centralized procurement market+off-standard non-medical insurance high-end alloy stents+medical insurance stainless steel stents+non-medical insurance ultra-high-end degradable stents.

In the short term, the market of cardiac stent products will form a pattern of low-cost medical insurance centralized procurement market+off-standard non-medical insurance high-end alloy stent+medical insurance stainless steel stent+non-medical insurance ultra-high-end degradable stent:

On the one hand, from the current attitude of centralized mining, bare metal stents are not included in the list of centralized mining, and the price of stainless steel stents will be under pressure due to the price reduction of centralized mining in the short term, and the price inversion with alloy stents will not last long; In the long run, stainless steel stents are not as good as alloy stents in terms of support and passability. As a more backward technology than Co-Cr alloy and Pt-Cr alloy, stainless steel stents will face marginalization in the future. However, in view of the fact that the use of stainless steel coronary stents still accounts for about 40% of the market share in 2019, stainless steel coronary stents will be coasting for a period of time in the future.

On the other hand, with the continuous promotion of cardiac stent collection, the trend of differentiation and stratification of end patients will become more obvious, and the group of self-paid high-priced stents may expand. Degradable stents and metal stents belong to two price bands, so it is impossible to talk about the market share substitution after the huge change of centralized purchasing price. Moreover, the proportion of consumables in the cost of PCI surgery has further decreased, and the audience’s marginal willingness to pay for innovative products is likely to increase. In the medium term, the development rhythm of fully degradable stents will continue to be stable, in order to get as much clinical data as possible, enhance the recognition and acceptance of products by more experts, doctors and patients, and enhance the high-end market share.

Figure 13 Future product layout of cardiac stent

2. Business reshaping: cultivate and expand new medical formats around the cardiovascular field, and make a forward-looking and diversified layout.

On the one hand, it conforms to the latest concept of "intervention without implantation" of the current interventional instruments, and extends upstream and downstream around the coronary intervention chain:

Product chain: the price reduction of metal stents will be the norm in the future, and the fully degradable stents and drug balloons with "intervention without implantation" will become the core of future development. Facing the policy impact of centralized stent mining, it will be an effective hedging means to extend the layout of coronary intervention chain. In addition to completely degradable stents, a new generation of drug-coated balloon (DCB) has also become the core of future development under the new concept of "interventional non-implantation". The data shows that the usage of drug-coated balloons in some hospitals or individuals in Europe has reached 50%-90% of all PCI, and Japan has reached 4,000 per month, accounting for about 15% of Japanese PCI. In addition, auxiliary consumables (balloons, catheters, guide wires, etc.) related to coronary intervention will also become the profit growth point that enterprises pay attention to.

Technical service chain: The further decline in the proportion of consumables in the cost of PCI surgery has prompted enterprises to speed up the layout of medical services and health management sectors. Conditional enterprises will cooperate with primary hospitals to provide equipment consumables, drugs and medical technical services needed for interventional diagnosis and treatment, and promote the grassroots promotion and popularization of new interventional technologies, which will become an important exploration for coronary intervention enterprises to face the centralized procurement of high-value consumables.

On the other hand, the centralized procurement of cardiac stents has prompted enterprises to expand from coronary intervention to peripheral intervention, and continuously enrich their product lines:

Make full use of enterprise stent balloon design and precision manufacturing platform technology, constantly innovate and develop, expand the company’s products from coronary intervention to peripheral intervention, continuously enrich the cardiovascular disease product line, and concentrate on improving the company’s marketing network structure to cope with market risks brought about by policy uncertainty.

Figure 14 Possible business development direction of cardiac stent enterprises under the background of centralized procurement

(C) changes in the market

Under the general trend and background of medical insurance fee control and national centralized procurement, it has a great influence on the competition pattern of domestic medical industry. Medical device enterprises will face more fierce market competition, as well as the realistic problems of product prices and product profit margins falling sharply. For the leading enterprises in the industry, although they can seize more market share by winning the bid at a low price, the problem of shrinking scale and declining profit rate cannot be underestimated.

In the foreseeable future, the scope of domestic medical insurance control fees will only increase, so as to more effectively reduce the pressure of medical insurance expenditure, reduce the prices of drugs and devices and benefit the people’s livelihood. In addition, the situation in the field of devices may appear in the previous pharmaceutical field, and importers may take more aggressive quotations to seize the domestic market after they are familiar with the rules.

For domestic cardiac stent enterprises, facing the policy risks of centralized procurement and medical insurance control, they need to seize the domestic share, turn their attention to the international market and participate in the international market competition. In fact, domestic heart stent head enterprises have also started the international strategic layout, among which minimally invasive medical care, Lepu medical care and Lan Fan medical care are typical representatives.

Turn: Transforming into a strategic choice for heart stent enterprises to overtake in corners.

In the face of major changes in the national medical device policy, cardiac stent enterprises actively predict the development trend, plan ahead, and focus on developing products and new businesses related to centralized procurement while strengthening product technology innovation. For domestic heart stent enterprises, what transformation layouts have been made at present? What is the possible key direction of development in the future?

(1) Adjust the business strategic map and form a multi-sector support system.

1. Diversification of business lines-minimally invasive medical treatment

Through business diversification, we will continuously broaden profit points and enhance comprehensive competitiveness. In recent years, Minimally Invasive Medical Devices Co., Ltd. (hereinafter referred to as "Minimally Invasive Medical") has continuously enriched its product line and expanded its business field through outreach acquisition and endogenous development. Products gradually changed from early cardiovascular stents to diversified business systems covering cardiovascular intervention, orthopedic medical devices, heart rate management (pacemaker), arterial and peripheral vascular intervention, and nerve intervention products.

In 2019, the business revenue was 5.55 billion yuan, of which 33.4% came from cardiovascular interventional products, 29.3% from orthopedic medical devices, 26.3% from heart rhythm management business, 6.1% from arterial and peripheral vascular interventional products, and 3.5% from neurological interventional products. In 2012, the revenue of minimally invasive medical cardiovascular interventional products (stents) accounted for 83.8%.

Figure 15 Comparison of the proportion of minimally invasive medical business segments in 2012 and 2019 (data source: minimally invasive medical annual report)

2. Product line "from one to four", and build a platform business model of "equipment+medicine+medical service+new medical care"-Lepu Medical.

Lepu (Beijing) Medical Devices Co., Ltd. (hereinafter referred to as "Lepu Medical"), as one of the earlier enterprises engaged in the research and development of cardiovascular interventional medical devices in China, has been accelerating the business integration, optimization and layout in recent years, and has developed from a single stent business in 2013 to four business segments covering "devices+drugs+medical services+new medical care" at present, with the goal of building a platform-based business model around the whole life cycle service for cardiovascular patients.

Figure 16 Main contents of each business segment of Lepu Medical

Dual track of medical devices and medicines: In terms of revenue, the revenue of Lepu Medical in 2019 was 7.80 billion yuan, a year-on-year increase of 22.6%. Among them, the medical device sector achieved operating income of 3.62 billion yuan, accounting for 46.4%, and the pharmaceutical sector achieved revenue of 38.5%, accounting for 49.4%. Among them, the revenue of coronary stent system only accounts for 20% of the total revenue of Lepu Medical. In addition, the market share of the company will be directly increased after winning the bid, and the negative impact of centralized procurement is relatively limited.

Figure 17 Revenue Ratio of Lepu Medical in 2019 (Source: Lepu Medical Annual Report)

3. "Health protection+medical equipment" two-wheel drive-Lan Fan Medical

Lan Fan Medical Co., Ltd. (hereinafter referred to as "Lan Fan Medical") is a leading enterprise in the field of medical gloves in the world, accounting for 22% of the global market. In 2018, it successfully acquired the fourth-ranked cardiac stent company in the world, Singapore Baisheng International Group, and realized its layout in the field of medical devices. Subsequently, Lan Fan Medical implemented the "A+X" industrial strategy, and set up four business divisions with a total of seven tracks:

Figure 18 Layout of Lan Fan Medical Industry

At present, Lan Fan Medical has two business series products, namely health protective gloves and heart stents, which are continuously extended to the whole chain of emergency care, cardiovascular and cerebrovascular diseases, forming a multi-business sector collaborative model combining low-value, medium-value and high-value consumables products, with complementary modes and risk hedging. In 2019, Lan Fan Medical achieved a revenue of 3.48 billion yuan, of which the revenue of health protective gloves was 1.68 billion yuan, accounting for 48.3%, and the revenue of cardiac interventional devices (including self-produced and agents) was 1.74 billion yuan, accounting for 50.0%.

Figure 19 Revenue Ratio of Lan Fan Medical in 2019 (Source: Lan Fan Medical Annual Report)

(2) Expand the cardiovascular product chain and form a diversified ecological closed loop.

1. Strategic positioning of big heart-minimally invasive medical treatment

Based on its own existing technology and platform, minimally invasive medical care constantly lays out big heart tracks: coronary heart disease, arrhythmia, structural heart disease and heart failure.

Development contextMinimally invasive medical care started from coronary stent, then cut into radiofrequency ablation, and then extended to pacemaker business. Later, with the further development of interventional technology, structural heart disease entered the era of minimally invasive surgery, and minimally invasive medical care opened up the technical path of completing heart valve replacement by interventional method (representative product VitaFlow transcatheter aortic valve system). Compared with these business units with mature products, Minimally Invasive has begun to "plan the layout" of the treatment solution for heart failure, which is also an important pawn for the future layout of Minimally Invasive and the key to completing the closed loop of the big heart business.

2. Optimize iterative coronary medical devices, enrich and innovate the implantable product line-Lepu Medical.

Lepu Medical has built a rich product group of devices in the cardiovascular field:

1) Accelerate the industrial chain matching of coronary intervention devices. In 2019, Lepu medical coronary stent products achieved operating income of 1.53 billion yuan, a year-on-year increase of 23.3%; Supporting auxiliary consumables (balloon catheter, guide wire, etc.) realized an operating income of 260 million yuan, up 51.0% year-on-year. Under the background that most of the auxiliary PCI interventional materials such as balloon catheter guide wire are monopolized by foreign capital, Lepu Medical is the only R&D and manufacturing enterprise in China that can provide all the consumables for coronary intervention. At present, more than ten necessary consumables such as pre-expanded and post-expanded balloon catheter, PTCA guide wire, guide catheter, contrast guide wire, contrast catheter, sheath, Y valve, triple tee, pressure extension tube, pressure pump, ring handle syringe, pressure sensor and hemostasis compressor have all been mass-produced.

2) Coronary balloon products and NeoVas bioabsorbable stents are expected to form new growth points. In February 2019, NeoVas, an international second-generation bioabsorbable drug stent independently developed by Lepu Medical, was approved for listing in China, and opened a new era of PCI technology "intervention without implantation". In July 2019, the first-generation coronary balloon was approved by GMP for the first time. Three products of the second-generation drug balloon series are about to start clinical trials, and the third-generation rapamycin drug balloon technology has made breakthrough progress, and animal experiments will be carried out soon.

In addition, in recent years, Lepu has actively developed peripheral products of degradable and drug balloons based on the Group’s coronary stent and balloon platform technology, and its business scope has expanded from coronary intervention to peripheral intervention.

3. Layout of coronary artery, valve, nerve intervention and peripheral intervention-Lan Fan Medical.

At the time when the medical device industry entered the golden period of development, Lan Fan Medical continuously accelerated the overall layout of cardiovascular and cerebrovascular devices based on the leading edge of Baisheng International Cardiology Department:

In the field of coronary intervention: all kinds of stent products produced by Singapore Baisheng International are sold to more than 90 countries and regions around the world, with a sales volume of 400,000. At present, BioFreedom, a drug-coated stent of BA9? without polymer carrier, has been introduced into European and Japanese markets, and it is expected to be listed in the United States and China in the near future. From the perspective of stent technology, the upgrading of technology is still the theme of stent industry and the driving force of sales growth. The increase in the proportion of high-end stents such as BioFreedom and Excrossal, as well as the development of foreign markets, have helped to enter the new product bonus period. In addition, taking the cardiac stent as the fulcrum, we will enrich, expand and improve the product line combination related to PCI surgery, such as contrast guide wire, contrast catheter, guide wire, guide catheter, pre-expanded balloon, post-expanded balloon, puncture needle, arterial sheath and pressure extension tube.

Cardiovascular related product lines: Apart from coronary artery, valve, nerve intervention and peripheral intervention are also the tracks that Lan Fan Medical keeps cutting in. By continuously expanding and expanding related product lines such as valve, nerve intervention, peripheral intervention and drug balloon, the competitiveness of product portfolio will be enhanced. The capital is undoubtedly the quickest way for Lan Fan Medical to broaden the track. In June, 2020, Lan Fan Medical acquired the fifth manufacturer of TAVR in the European market. NVT’s main business is the research and development, production and sales of interventional valves for structural heart disease. Through the acquisition of TAVR, a gold track for medical devices, NVT officially entered the field of minimally invasive interventional structural heart disease therapy with broad prospects.

(C) the implementation of internationalization strategy to enhance the international market share of products.

1. Actively deploy the global mainstream market-minimally invasive medical care.

Since 2014, minimally invasive medical care has set its sights on overseas and accelerated the export of China native coronary stents to overseas markets. In 2019, the overseas business of minimally invasive medical drug-eluting stents achieved revenue of 160 million yuan, a year-on-year increase of 72.4%. Sales in 25 countries or regions and registration certificates in 13 countries or regions. Among them, Firebird2TM’s overseas revenue increased by 186.9% year-on-year, FirehawkTM’s revenue increased by 54.6% year-on-year, and it has been sold in several major European countries. In addition, the group has also submitted the application for registration of FirehawkTM stent to the Japanese medical device review and approval authority, and actively deployed the global mainstream market.

Figure 20 Sub-regional Income Ratio of Minimally Invasive Medical Care in 2019 (Source: Minimally Invasive Medical Annual Report)

2. Establish an international business department to increase the market share of international innovative products-Lepu Medical.

Lepu Medical put internationalization on the agenda after the first round of domestic drug collection in 2018, and proposed to further increase the market share of international innovative products. At present, the original foreign trade business and departments of all subsidiaries have been integrated, and the international business department has been established to strengthen the international influence on the upstream and downstream of the medical industry chain in the cardiovascular field. Explore the possibility of setting up R&D centers and production bases overseas. Overseas R&D centers have been planned to accelerate the clinical registration of innovative products (degradable stents, TAVR3.0, renal artery ablation, artificial intelligence ECG and artificial intelligence monitoring) in the world.

It is reported that Lepu Medical’s business revenue from abroad in the first half of 2020 was 870 million yuan, an increase of 320 million yuan compared with the whole year of 2019. Guo Tongjun, senior deputy general manager and secretary of the board of directors of Lepu Medical, said at the reception of listed companies that the company’s overseas market target remains unchanged, and the proportion of overseas market revenue will continue to increase to 20%-30% in the next 3-5 years.

Figure 21 Lepu Medical Internationalization Strategic Measures

summarize

National centralized procurement is not only a reshuffle of the cardiac stent industry, but also an impetus to the cardiovascular segmentation field. Heart stent enterprises still have a long way to go, but whether they are facing the "change" of the industry calmly or actively responding to the "turn" of the industry, there are undoubtedly two ways to go: First, strengthen the technological innovation and product iteration of heart stents in order to obtain new user markets; The second is to realize business diversification and risk hedging with the heart stent as the fulcrum.

The survival simulation card game ＂Card Survival： Fantasy Forest＂ was put on the shelves of Steam.

　　Recently, the survival simulation card game "Card Survival: Fantasy Forest" developed and distributed by WinterSpring Games has been put on the Steam platform. This game does not support Chinese for the time being, and the release date is unknown.

Ranger network 1

The game is introduced:

　　Card Survival: Fantasy Forest Card Survival: Fantasy Forest will be a card-based deep survival simulator and the next game in the card survival series. Create a home with independent will for yourself in the virgin forest. Simulate your daily life in a natural world full of mystery, beauty and cruelty.

Game features:

　　Simple and deep system:

　　Deep and detailed survival simulator based on cards. The card mechanism makes it easy for players to get started and leaves room for imagination to give players a unique experience.

　　All interactions are done by using cards or combining them together.

Living forest ecosystem:

　　Participate in a complex ecosystem, which has the power of dynamic simulation (including animal and plant populations). These forces can operate independently, but they can be meaningfully influenced by your behavior. Experience the cyclical nature of life through four different seasons and a complete weather system.

Realistic simulation system:

　　Simulate digestive and immune systems, wound types and their healing process, and psychological states including anxiety, mania, depression and mental disorders. Track physical and chemical indexes from weight, calluses to diarrhea degree.

Game screenshot:

Ranger 2

Ranger 3

Ranger network 4